Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders.

Immunology
Hassan JamaleddineAnmar Khadra

Abstract

Nanoparticles (NPs) displaying autoimmune disease-relevant peptide-major histocompatibility complex class II molecules (pMHCII-NPs) trigger cognate T-regulatory type 1 (Tr1)-cell formation and expansion, capable of reversing organ-specific autoimmune responses. These pMHCII-NPs that display epitopes from mitochondrial protein can blunt the progression of both autoimmune hepatitis (AIH) and experimental autoimmune encephalomyelitis (EAE) in mice carrying either disease. However, with co-morbid mice having both diseases, these pMHCII-NPs selectively treat AIH. In contrast, pMHCII-NPs displaying central nervous system (CNS)-specific epitopes can efficiently treat CNS autoimmunity, both in the absence and presence of AIH, without having any effects on the progression of the latter. Here, we develop a compartmentalized population model of T-cells in co-morbid mice to identify the mechanisms by which Tr1 cells mediate organ-specific immunoregulation. We perform time-series simulations and bifurcation analyses to study how varying physiological parameters, including local cognate antigenic load and rates of Tr1-cell recruitment and retention, affect T-cell allocation and Tr1-mediated immunoregulation. Various regimes of behaviour, inc...Continue Reading

References

May 1, 1997·European Journal of Immunology·T De SmedtM Moser
Mar 22, 2003·Current Opinion in Cell Biology·John J TysonBela Novak
May 27, 2006·International Immunology·Athanasius F M MaréeLeah Edelstein-Keshet
Feb 3, 2007·Journal of Theoretical Biology·Peter S KimDoron Levy
Oct 28, 2008·Journal of Theoretical Biology·Anmar KhadraLeah Edelstein-Keshet
Nov 26, 2008·Arthritis Research & Therapy·Jörg J Goronzy, Cornelia M Weyand
Dec 30, 2008·Advances in Immunology·Sue TsaiPere Santamaria
Apr 7, 2010·Current Opinion in Immunology·Julie M Curtsinger, Matthew F Mescher
May 26, 2010·International Immunology·Anmar KhadraLeah Edelstein-Keshet
Aug 16, 2011·Seminars in Immunology·Caroline PotVijay K Kuchroo
Mar 29, 2012·Autoimmune Diseases·Adriana Rojas-VillarragaJuan-Manuel Anaya
Apr 30, 2013·Nature Medicine·Nicola GaglianiMaria-Grazia Roncarolo
Feb 24, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pau Serra, Pere Santamaria
Aug 15, 2015·Journal of Theoretical Biology·Majid Jaberi-DourakiAnmar Khadra
Feb 18, 2016·Nature·David Wraith
Feb 18, 2016·Nature·Xavier Clemente-CasaresPere Santamaria
May 26, 2016·The New England Journal of Medicine·Jagadeesh Bayry
Apr 25, 2017·Nature Nanotechnology·Santiswarup SinghaPere Santamaria
May 10, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aakanksha Jain, Chandrashekhar Pasare
Mar 20, 2019·Frontiers in Immunology·Jesús GálvezPilar García-Peñarrubia
May 16, 2019·Nature Communications·Channakeshava Sokke UmeshappaPere Santamaria
Mar 4, 2020·The Journal of Clinical Investigation·Channakeshava Sokke UmeshappaPere Santamaria

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Israel Journal of Medical Sciences
E MozesH Fricke
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
M Nishioka
© 2021 Meta ULC. All rights reserved